Our extensive database of Harvard technologies is available for new product development opportunities that will strengthen your strategic portfolio.

Available Technology

Vaccine compositions and methods for Human Papilloma Virus



Technology:
Methods of HPV protein expression, purification of expressed proteins, and use in vaccine and diagnostic technologies

Markets Addressed


This invention is suitable in the development and application of vaccine and diagnostic technologies for the Human Papilloma Virus (HPV).

Innovations and Advantages


This invention comprises methods of expressing the Human Papilloma Virus L1 and L2 proteins, and variations thereof, in bacterial host cells; the purification of the expressed proteins; and their use in the development and application of vaccine and diagnostic technologies.

Additional Information


Intellectual Property Status: Issued U.S. patent nos.: 6,551,597





Inventor(s):
    Chen, Xiaojiang
    Harrison, Stephen C.

Categories:
For further information, please contact:
Grant Zimmermann, Director of Business Development
(617) 495-3067
Reference Harvard Case #1558